The Recovery Spot Now Open In Malibu and San Diego!

What we Offer

Medicated Assisted Therapies
Medication Assisted Treatment

Addiction treatment that includes the use of medication along with counseling. Examples include Probuphine Implants, Vivitrol Injections, & Buprenorphine.

Read More
Ketamine Infusions

Ketamine has been proven to re-develop neural pathways in the brain that have been damaged by Depression. Ketamine has been known to help PTSD and other underlying conditions.

Read More
Dual Diagnosis Treatment

The Recovery Spot provides proper diagnosis and treatment of any co-occurring mental health disorder(s) is key when evaluating and treating those suffering with addiction.

Read More
Ayurvedic Wellness

Natural health care approach for wellness using many treatment models. The treatments used include standard Western or allopathic medicine, Ayurveda, natural energy medicine.

Read More
Pain Management

Pain management utilizing state of the art techniques. We offer non-narcotic treatments to help you get out of pain today. Over 30 years experience utilizing Ayurveda and other ground breaking techniques.

Read More



The U.S. Food and Drug Administration today approved Probuphine, the first buprenorphine implant for the maintenance treatment of opioid dependence. Probuphine is designed to provide a constant, low-level dose of buprenorphine for six months in patients who are already stable on low-to-moderate doses of other forms of buprenorphine, as part of a complete treatment program.


The use of naltrexone was first approved for the treatment of opiate dependence in 1984 and for alcohol dependence in 1994. In 2006, Vivitrol, a new formulation of this medication was approved for alcohol and in 2010 Vivitrol was approved for the prevention of relapse to opiate dependence. Naltrexone does not cause an antabuse-like aversion


The FDA has approved Sublocade (Indivior, Inc.), the first once-monthly buprenorphine injection for the treatment of moderate-to-severe opioid use disorder (OUD) in adults who have initiated treatment with a transmucosal buprenorphine-containing product. It is indicated for patients who have been on a stable dose of buprenorphine treatment for at least seven days. Buprenorphine for OUD


Ketamine for the treatment of addiction: Evidence and potential mechanisms. Ketamine is a dissociative anaesthetic drug which acts on the central nervous system chiefly through antagonism of the n-methyl-d-aspartate (NMDA) receptor. Recently, ketamine has attracted attention as a rapid-acting anti-depressant but other studies have also reported its efficacy in reducing problematic alcohol and drug use.

Our Dedicated Team

Scott Bienenfeld, MD

Addiction Psychiatrist/Co-Director

Ramesh Sawhney, MD, DABA


Parmela Sawhney, MD

Ayurvedic Specialist

Peter Grayson

Director of Programming

Tom Horvath, PhD., ABPP

Psychologist, Addiction Expert

Ed Hess, MD


Alex Malinovskis

Chief Financial Officer

Jay Petsko

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium dolore mque laudantim.

The Recovery Spot Welcomes Tom Horvath

We are excited to partner collaboratively with Practical Recovery Psychology Group to integrate our medical treatment with Practical Recovery’s psycho-therapeutic modalities.

Tom Horvath, Ph.D., is a California licensed and board certified clinical psychologist (ABPP), founder and CEO of Practical Recovery, a San Diego based self-empowering addiction treatment system, was one of the founders of SMART Recovery (in 1994) and was president of SMART Recovery for 20 years. SMART is an international, non-profit network of free, self-empowering, science-based mutual help groups for resolving any problematic addictive behavior. He is past president of the American Psychological Association’s Society of Addiction Psychology (Division 50), the world’s largest organization of addiction psychologists.  Read More >>

REquest Service

Enter your contact details here to help us serve you better & faster.